Konsekwencje polimorfizmu rs6265 (Val66Met) genu BDNF w wybranych zaburzeniachpsychicznych i sporcie

Autor

DOI:

https://doi.org/10.2478/cpp-2022-0003

Słowa kluczowe:

BDNF, depresja, sport, uzależnienia, polimorfizm

Abstrakt

Wstęp. Neurotroficzny czynnik pochodzenia mózgowego (BDNF) jest polipeptydem składającym się z 247 reszt aminokwasowych i jest szeroko rozpowszechniony w ośrodkowym układzie nerwowym (OUN) . Odgrywa ważną rolę w przeżyciu, różnicowaniu, wzroście i rozwoju neuronów w ośrodkowym układzie nerwowym człowieka. Ludzki gen BDNF znajduje się na chromosomie 11 w regionie p13-14 i obejmuje około 70 kb. Gen ma złożoną strukturę, ponieważ składa się z 11 eksonów (I-IX oraz Vh i VIIIh) i dziewięciu funkcjonalnych promotorów. Ekspresja BDNF w mózgu jest stosunkowo niska, ale występuje w większości głównych obszarów mózgu.

Materiał i metody. Gen kodujący neurotroficzny czynnik pochodzenia mózgowego BDNF ma wiele polimorfizmów, ale jeden z nich przede wszystkim przyciąga uwagę badaczy. Jest to powszechny, niekonserwatywny polimorfizm – rs6265 – polimorfizm pojedynczego nukleotydu SNP, który powoduje zmianę aminokwasu – waliny (Val) na metioninę (Met) – w kodonie 66.

Dyskusja. Polimorfizm rs6265 związany jest z wieloma zaburzeniami neuropsychiatrycznymi, w tym z depresją oraz uzależnieniami, a także determinuje inne cechy organizmu, takie jak np. osiągnięcia sportowe. Niewiele badań analizuje związek między polimorfizmem rs6265 a predyspozycją do uprawiania sportu.

Wnioski. Wyniki badań naukowych dotyczących wpływu wariantów polimorficznych rs6265 BDNF na ryzyko depresji i uzależnień są niespójne. Dlatego potrzebne są dalsze eksperymenty, aby wiarygodnie określić, w jaki sposób rs6265 wpływa na ekspresję i funkcję genu.

Bibliografia

1. Ayyadhury, S.; Heese, K. Neurotrophins - More than Neurotrophic. Current Immunology Reviews 2007, 3, 189-215. https://doi.org/10.2174/157339507781483504.

2. Kelley, A.E.; Berridge, K.C. The Neuroscience of Natural Rewards: Relevance to Addictive Drugs. The Journal of neuroscience: the official journal of the Society for Neuroscience2002, 22, 3306-3311. https://doi.org/10.1523/JNEUROSCI.22-09-03306.2002.

3. Li, Y.; Xia, B.; Li, R.; Yin, D.; Liang, W. Changes in Expression of Dopamine, Its Receptor, and Transporter in Nucleus Accumbens of Heroin-Addicted Rats with Brain-Derived Neurotrophic Factor (BDNF) Overexpression. Medical Science Monitor 2017, 23, 2805-2815. https://doi.org/10.12659/MSM.904670.

4. le Foll, B.; Diaz, J.; Sokoloff, P. A Single Cocaine Exposure Increases BDNF and D3 Receptor Expression: Implications for Drug-Conditioning. NeuroReport2005, 16, 175-178. https://doi.org/10.1097/00001756-200502080-00022.

5. Robinson, T.E.; Berridge, K.C. The Neural Basis of Drug Craving: An Incentive-Sensitization Theory of Addiction. Brain Research Reviews 1993, 18, 247-291.

6. Barde, Y.A.; Edgar, D.; Thoenen, H. Purification of a New Neurotrophic Factor from Mammalian Brain. The EMBO Journal1982, 1, 549. https://doi.org/10.1002/j.1460-2075.1982.tb01207.x.

7. Chao, M. V.; Bothwell, M. Neurotrophins: To Cleave or Not to Cleave. Neuron2002, 33, 9-12. https://doi.org/10.1016/S0896-6273(01)00573-6.

8. Lee, R.; Kermani, P.; Teng, K.K.; Hempstead, B.L. Regulation of Cell Survival by Secreted Proneurotrophins. Science (New York, N.Y.)2001, 294, 1945-1948. https://doi.org/10.1126/SCIENCE.1065057.11729324

9. Pang, P.T.; Teng, H.K.; Zaitsev, E.; Woo, N.T.; Sakata, K.; Zhen, S.; Teng, K.K.; Yung, W.H.; Hempstead, B.L.; Lu, B. Cleavage of ProBDNF by TPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity. Science (New York, N.Y.)2004, 306, 487-491. https://doi.org/10.1126/SCIENCE.1100135.

10. Teng, H.K.; Teng, K.K.; Lee, R.; Wright, S.; Tevar, S.; Almeida, R.D.; Kermani, P.; Torkin, R.; Chen, Z.Y.; Lee, F.S.; et al. ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of P75NTR and Sortilin. The Journal of neuroscience: the official journal of the Society for Neuroscience 2005, 25, 5455-5463. https://doi.org/10.1523/JNEUROSCI.5123-04.2005.672499215930396

11. Fleitas, C.; Piñol-Ripoll, G.; Marfull, P.; Rocandio, D.; Ferrer, I.; Rampon, C.; Egea, J.; Espinet, C. ProBDNF Is Modified by Advanced Glycation End Products in Alzheimer’s Disease and Causes Neuronal Apoptosis by Inducing P75 Neurotrophin Receptor Processing 11 Medical and Health Sciences 1109 Neurosciences. Molecular Brain2018, 11, 1-16. https://doi.org/10.1186/S13041-018-0411-6/FIGURES/5.

12. Minichiello, L. TrkBSignalling Pathways in LTP and Learning. Nature reviews. Neuroscience2009, 10, 850-860. https://doi.org/10.1038/NRN2738.

13. Zhang, J.; Yao, W.; Hashimoto, K. Brain-Derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-Related Depression and Potential Therapeutic Targets. Current neuropharmacology2016, 14, 721-731. https://doi.org/10.2174/1570159X14666160119094646.

14. Finn, R.D.; Coggill, P.; Eberhardt, R.Y.; Eddy, S.R.; Mistry, J.; Mitchell, A.L.; Potter, S.C.; Punta, M.; Qureshi, M.; Sangrador-Vegas, A.; et al. The Pfam Protein Families Database: Towards a More Sustainable Future. Nucleic acids research2016, 44, D279-D285. https://doi.org/10.1093/NAR/GKV1344.

15. Seidaha, N.G.; Benjannet, S.; Pareek, S.; Chrétien, M.; Murphy, R.A. Cellular Processing of the Neurotrophin Precursors of NT3 and BDNF by the Mammalian Proprotein Convertases. FEBS letters1996, 379, 247-250. https://doi.org/10.1016/0014-5793(95)01520-5.

16. Pagni, M.; Ioannidis, V.; Cerutti, L.; Zahn-Zabal, M.; Jongeneel, C.V.; Hau, J.; Martin, O.; Kuznetsov, D.; Falquet, L. MyHits: Improvements to an Interactive Resource for Analyzing Protein Sequences. Nucleic Acids Research2007, 35, W433. https://doi.org/10.1093/NAR/GKM352.

17. Notaras, M.; van den Buuse, M. Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation. Neuroscient ist2019, 25, 434-454. https://doi.org/10.1177/1073858418810142.30387693

18. Mowla, S.J.; Farhadi, H.F.; Pareek, S.; Atwal, J.K.; Morris, S.J.; Seidah, N.G.; Murphyl, R.A. Biosynthesis and Post-Translational Processing of the Precursor to Brain-Derived Neurotrophic Factor. The Journal of biological chemistry2001, 276, 12660-12666. https://doi.org/10.1074/JBC.M008104200.11152678

19. D’Addario, C.; Dell’Osso, B.; Galimberti, D.; Palazzo, M.C.; Benatti, B.; Di Francesco, A.; Scarpini, E.; Altamura, A.C.; MacCarrone, M. Epigenetic Modulation of BDNF Gene in Patients with Major Depressive Disorder. Biological psychiatry2013, 73. https://doi.org/10.1016/J.BIOPSYCH.2012.07.009.22901293

20. Pruunsild, P.; Kazantseval, A.; Aid, T.; Palm, K.; Timmusk, T. Dissecting the Human BDNF Locus: Bidirectional Transcription, Complex Splicing, and Multiple Promoters. Genomics2007, 90, 397-406. https://doi.org/10.1016/J.YGENO.2007.05.004.256888017629449

21. An, J.J.; Gharami, K.; Liao, G.Y.; Woo, N.H.; Lau, A.G.; Vanevski, F.; Torre, E.R.; Jones, K.R.; Feng, Y.; Lu, B.; et al. Distinct Role of Long 3’ UTR BDNF MRNA in Spine Morphology and Synaptic Plasticity in Hippocampal Neurons. Cell2008, 134, 175-187. https://doi.org/10.1016/J.CELL.2008.05.045.252720718614020

22. Lau, A.G.; Irier, H.A.; Gu, J.; Tian, D.; Ku, L.; Liu, G.; Xia, M.; Fritsch, B.; Zheng, J.Q.; Dingledine, R.; et al. Distinct 3’UTRs Differentially Regulate Activity-Dependent Translation of Brain-Derived Neurotrophic Factor (BDNF). Proceedings of the National Academy of Sciences of the United States of America2010, 107, 15945-15950. https://doi.org/10.1073/PNAS.1002929107.

23. Matsumoto, T.; Rauskolb, S.; Polack, M.; Klose, J.; Kolbeck, R.; Korte, M.; Barde, Y. A. Biosynthesis and Processing of Endogenous BDNF: CNS Neurons Store and Secrete BDNF, Not pro-BDNF. Nature neuroscience2008, 11, 131-133. https://doi.org/10.1038/NN2038.

24. Lein, E.S.; Hawrylycz, M.J.; Ao, N.; Ayres, M.; Bensinger, A.; Bernard, A.; Boe, A.F.; Boguski, M.S.; Brockway, K.S.; Byrnes, E.J.; et al. Genome-Wide Atlas of Gene Expression in the Adult Mouse Brain. Nature 2006 445:71242006, 445, 168-176. https://doi.org/10.1038/nature05453.

25. Sohrabji, F.; Miranda, R.C.G.; Toran-Allerand, C.D. Identification of a Putative Estrogen Response Element in the Gene Encoding Brain-Derived Neurotrophic Factor. Proceedings of the National Academy of Sciences of the United States of America1995, 92, 11110. https://doi.org/10.1073/PNAS.92.24.11110.

26. Hill, R.A.; Wu, Y.W.C.; Kwek, P.; Van den Buuse, M. Modulatory Effects of Sex Steroid Hormones on Brain-Derived Neurotrophic Factor-Tyrosine Kinase B Expression during Adolescent Development in C57Bl/6 Mice. Journal of neuroendocrinology2012, 24, 774-788. https://doi.org/10.1111/J.1365-2826.2012.02277.X.

27. Yang, J.; Siao, C.J.; Nagappan, G.; Marinic, T.; Jing, D.; McGrath, K.; Chen, Z.Y.; Mark, W.; Tessarollo, L.; Lee, F.S.; et al. Neuronal Release of ProBDNF. Nature neuroscience2009, 12, 113-115. https://doi.org/10.1038/NN.2244.

28. Egan, M.F.; Kojima, M.; Callicott, J.H.; Goldberg, T.E.; Kolachana, B.S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; et al. The BDNF Val66met Polymorphism Affects Activity-Dependent Secret ion of BDNF and Human Memor y and Hippocampal Function. Cell2003, 112, 257-269. https://doi.org/10.1016/S0092-8674(03)00035-7.

29. Chen, Z.Y.; Patel, P.D.; Sant, G.; Meng, C.X.; Teng, K.K.; Hempstead, B.L.; Lee, F.S. Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons. Journal of Neuroscience2004, 24, 4401-4411. https://doi.org/10.1523/JNEUROSCI.0348-04.2004.672945015128854

30. Depression Available online: https://www.who.int/health-topics/depression#tab=tab_1 (accessed on 10 March 2022).

31. Fratelli, C.F.; Siqueira, J.W.; Gontijo, B.R.; Santos, M. de L.; Silva, C.M. de S.; Silva, I.C.R. da BDNF Genetic Variant and Its Genotypic Fluctuation in Major Depressive Disorder. Behavioural Neurology2021, 2021, 1-16. https://doi.org/10.1155/2021/7117613.857559834760029

32. Aldoghachi, A.F.; Tor, Y.S.; Redzun, S.Z.; Bin Lokman, K.A.; Abdul Razaq, N.A.; Shahbudin, A.F.; Badamasi, I.M.; Cheah, P.S.; Stanslas, J.; Veerakumarasivam, A.; et al. Screening of Brain-Derived Neurotrophic Factor (BDNF) Single Nucleotide Polymorphisms and Plasma BDNF Levels among Malaysian Major Depressive Disorder Patients. PLoS ONE2019, 14. https://doi.org/10.1371/JOURNAL.PONE.0211241.634545930677092

33. Hwang, J.P.; Tsai, S.J.; Hong, C.J.; Yang, C.H.; Lirng, J.F.; Yang, Y.M. The Val66Met Polymorphism of the Brain-Derived Neurotrophic-Factor Gene Is Associated with Geriatric Depression. Neurobiology of Aging2006, 27, 1834-1837. https://doi.org/10.1016/J.NEUROBIOLAGING.2005 .10.013.16343697

34. Taylor, W.D.; Züchner, S.; Mcquoid, D.R.; Steffens, D.C.; Speer, M.C.; Krishnan, K.R.R. Allelic Differences in the Brain-Derived Neurotrophic Factor Val66Met Polymorphism in Late-Life Depression. The American Journal of Geriatric Psychiatry2007, 15, 850-857. https://doi.org/10.1097/JGP.0B013E318050C9D5.17911362

35. Ribeiro, L.; Busnello, J. V.; Cantor, R.M.; Whelan, F.; Whittaker, P.; Deloukas, P.; Wong, M.-L.; Licinio, J. The Brain-Derived Neurotrophic Factor Rs6265 (Val66Met) Polymorphism and Depression in Mexican-Americans. Neuroreport2007, 18, 1291. https://doi.org/10.1097/WNR.0B013E328273BCB0.268683617632285

36. Youssef, M.M.; Underwood, M.D.; Huang, Y.Y.; Hsiung, S. chi; Liu, Y.; Simpson, N.R.; Bakalian, M.J.; Rosoklija, G.B.; Dwork, A.J.; Arango, V.; et al. Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide. International Journal of Neuropsychopharmacology2018, 21, 528. https://doi.org/10.1093/IJNP/PYY008.

37. Cruz-Fuentes, C.S.; Benjet, C.; Mar tínez-Levy, G.A.; Pérez-Molina, A.; Briones-Velasco, M.; Suárez-González, J. BDNF Met66 Modulates the Cumulative Effect of Psychosocial Childhood Adversities on Major Depression in Adolescents. Brain and Behavior2014, 4, 290. https://doi.org/10.1002/BRB3.220.

38. Sun, M.M.; Yang, L.M.; Wang, Y.; Feng, X.; Cui, K.Y.; Liu, L.F.; Chen, Z.Y. BDNF Val66Met Polymorphism and Anxiety/Depression Symptoms in Schizophrenia in a Chinese Han Population. Psychiatric genetics2013, 23, 124-129. https://doi.org/10.1097/YPG.0B013E328360C866.23532065

39. Kang, H.J.; Bae, K.Y.; Kim, S.W.; Shin, I.S.; Hong, Y.J.; Ahn, Y.; Jeong, M.H.; Yoon, J.S.; Kim, J.M. BDNF Val66met Polymorphism and Depressive Disorders in Patients with Acute Coronary Syndrome. Journal of affective disorders2016, 194, 1-8. https://doi.org/10.1016/J.JAD.2016.01.033.26795846

40. Verhagen, M.; Van Der Meij, A.; Van Deurzen, P.M.; Janzing, J.; Arias-Vásquez, A.; Buitelaar, J.; Franke, B. Meta-Analysis of the BDNF Val66Met Polymorphism in Major Depressive Disorder: Effects of Gender and Ethnicity. Molecular Psychiatry 2010 15:32008, 15, 260-271. https://doi.org/10.1038/mp.2008.109.18852698

41. Gyekis, J.P.; Yu, W.; Dong, S.; Wang, H.; Qian, J.; Kota, P.; Yang, J. No Association of Genetic Variants in BDNF With Major Depression: A Meta- and Gene-Based Analysis. American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics2013, 162, 61. https://doi.org/10.1002/AJMG.B.32122.372512823184535

42. Pei, Y.; Smith, A.K.; Wang, Y.; Pan, Y.; Yang, J.; Chen, Q.; Pan, W.; Bao, F.; Zhao, L.; Tie, C.; et al. The Brain-Derived Neurotrophic-Factor (BDNF) Val66met Polymorphism Is Associated with Geriatric Depression: A Meta-Analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics2012, 159B, 560-566. https://doi.org/10.1002/AJMG.B.32062.

43. Verhagen, M.; van der Meij, A.; van Deurzen, P.M.; Janzing, J.; Arias-Vásquez, A.; Buitelaar, J.; Franke, B. Meta-Analysis of the BDNF Val66Met Polymorphism in Major Depressive Disorder: Effects of Gender and Ethnicity. Molecular Psychiatry 2010 15:32008, 15, 260-271. https://doi.org/10.1038/mp.2008.109.18852698

44. Zou, Z.; Wang, H.; d’OleireUquillas, F.; Wang, X.; Ding, J.; Chen, H. Definition of Substance and Non-Substance Addiction. Advances in experimental medicine and biology 2017, 1010, 21-41. https://doi.org/10.1007/978-981-10-5562-1_2.29098666

45. Feng, J.; Nestler, E.J. Epigenetic Mechanisms of Drug Addiction. Current opinion in neurobiology. 2013, 23, 521-528. https://doi.org/10.1016/J.CONB.2013.01.001.

46. Global Overview: Drug Demand Drug Supply.

47. Europejski Raport Narkotykowy Tendencje i Osiągnięcia. https://doi.org/10.2810/251039.

48. Morris, R.G.M. Long-Term Potentiation and Memor y. Philosophical transactions of the Royal Society of London. Series B, Biological sciences2003, 358, 643-647. https://doi.org/10.1098/RSTB.2002.1230.169317112740109

49. Suriyaprom, K.; Tungtrongchitr, R.; Thawnashom, K.; Pimainog, Y. BDNF Val66Met Polymorphism and Serum Concentrations of BDNF with Smoking in Thai Males. Genetics and molecular research: GMR2013, 12, 4925-4933. https://doi.org/10.4238/2013.OCTOBER.24.3.24301752

50. Zhang, X.Y.; Chen, D.C.; Xiu, M.H.; Luo, X.; Zuo, L.; Haile, C.N.; Kosten, T.A.; Kosten, T.R. BDNF Val66Met Variant and Smoking in a Chinese Population. PloS one2012, 7. https://doi.org/10.1371/JOURNAL.PONE.0053295.353229423285275

51. Nees, F.; Witt, S.H.; Dinu-Biringer, R.; Lourdusamy, A.; Tzschoppe, J.; Vollstädt-Klein, S.; Millenet, S.; Bach, C.; Poustka, L.; Banaschewski, T.; et al. BDNF Val66Met and Reward-Related Brain Function in Adolescents: Role for Early Alcohol Consumption. Alcohol (Fayetteville, N.Y.)2015, 49, 103-110. https://doi.org/10.1016/J.ALCOHOL.2014.12.004.

52. Su, H.; Tao, J.; Zhang, J.; Xie, Y.; Sun, Y.; Li, L.; Xu, K.; Han, B.; Lu, Y.; Sun, H.; et al. An Association between BDNF Val66Met Polymorphism and Impulsivity in Methamphetamine Abusers. Neuroscience Letters2014, 582, 16-20. https://doi.org/10.1016/J.NEULET.2014.08.030.25168604

53. Montag, C.; Basten, U.; Stelzel, C.; Fiebach, C.J.; Reuter, M. The BDNF Val66Met Polymorphism and Smoking. Neuroscience letters2008, 442, 30-33. https://doi.org/10.1016/J.NEULET.2008.06.064.18602452

54. Wojnar, M.; Brower, K.J.; Strobbe, S.; Ilgen, M.; Matsumoto, H.; Nowosad, I.; Sliwerska, E.; Burmeister, M. Association between Val66Met Brain-Derived Neurotrophic Factor (BDNF) Gene Polymorphism and Post-Treatment Relapse in Alcohol Dependence. Alcoholism, clinical and experimental research2009, 33, 693. https://doi.org/10.1111/J.1530-0277.2008.00886.X.

55. Hou, H.; Qing, Z.; Jia, S.; Zhang, X.; Hu, S.; Hu, J. Influence of Brain-Derived Neurotrophic Factor (Val66Met) Genetic Polymorphism on the Ages of Onset for Heroin Abuse in Males. Brain Research2010, 1353, 245-248. https://doi.org/10.1016/J.BRAINRES.2010.07.022.

56. Iamjan, S.A.; Thanoi, S.; Watiktinkorn, P.; Nudmamud-Thanoi, S.; Reynolds, G.P. BDNF (Val66Met) Genetic Polymorphism Is Associated with Vulnerability for Methamphetamine Dependence. PHARMACOGENOMICS2015, 16, 1541-1545. https://doi.org/10.2217/PGS.15.96.

57. Nedic, G.; Nikolac Perkovic, M.; Nenadic Sviglin, K.; Muck-Seler, D.; Borovecki, F.; Pivac, N. Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Alcohol-Related Phenotypes. Progress in Neuro-Psychophar macology and Biological Psychiatry2013, 40, 193-198. https://doi.org/10.1016/J.PNPBP.2012.09.005.

58. Meng, C.; Lan, J.; Wang, Y.; Song, M.; Gao, X.; Ran, L.; Moira, S.; Wang, W. Influence of Brain-Derived Neurotrophic Factor Genetic Polymorphisms on the Ages of Onset for Heroin Dependence in a Chinese Population. Genetic testing and molecular biomarkers2012, 16, 1044-1050. https://doi.org/10.1089/GTMB.2012.0016.

59. Su, N.; Zhang, L.; Fei, F.; Hu, H.; Wang, K.; Hui, H.; Jiang, X.F.; Li, X.; Zhen, H.N.; Li, J.; et al. The Brain-Derived Neurotrophic Factor Is Associated with Alcohol Dependence-Related Depression and Antidepressant Response. Brain research2011, 1415, 119-126. https://doi.org/10.1016/J.BRAINRES.2011.08.005.

60. Tajbakhsh, A.; Alimardani, M.; Asghari, M.; Abedini, S.; SaghafiKhadem, S.; NesaeiBajestani, A.; Alipoor, F.; Alidoust, M.; Savardashtaki, A.; Hashemian, P.; et al. Association of PICK1 and BDNF Variations with Increased Risk of Methamphetamine Dependence among Iranian Population: A Case-Control Study. BMC medical genomics2021, 14. https://doi.org/10.1186/S12920-021-00873-7.

61. De Moor, M.H.M.; Spec tor, T.D.; Cherk as, L. F.; Falchi, M.; Hottenga, J.J.; Boomsma, D.I.; De Geus, E.J.C. Genome-Wide Linkage Scan for Athlete Status in 700 British Female DZ Twin Pairs. Twin research and human genetics: the official journal of the International Society for Twin Studies2007, 10, 812-820. https://doi.org/10.1375/TWIN.10.6.812.

62. Egan, M.F.; Kojima, M.; Callicott, J.H.; Goldberg, T.E.; Kolachana, B.S.; Bertolino, A.; Zaitsev, E.; Gold, B.; Goldman, D.; Dean, M.; et al. The BDNF Val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function. Cell2003, 112, 257-269. https://doi.org/10.1016/S0092-8674(03)00035-7.

63. Murtagh, C.F.; Brownlee, T.E.; Rienzi, E.; Roquero, S.; Moreno, S.; Huertas, G.; Lugioratto, G.; Baumert, P.; Turner, D.C.; Lee, D.; et al. The Genetic Profile of Elite Youth Soccer Players and Its Association with Power and Speed Depends on Maturity Status. PLoS ONE2020, 15. https://doi.org/10.1371/JOURNAL.PONE.0234458.730777632569264

64. Kambouris, M.; Ntalouka, F.; Ziogas, G.; Maffulli, N. Predictive Genomics DNA Profiling for Athletic Performance. Recent Patents on DNA and Gene Sequences2012, 6, 229-239. https://doi.org/10.2174/187221512802717321.22827597

65. Lemos, J.R.; Alves, C.R.; de Souza, S.B.C.; Marsiglia, J.D.C.; Silva, M.S.M.; Pereira, A.C.; Teixeira, A.L.; Vieira, E.L.M.; Krieger, J.E.; Negrão, C.E.; et al. Peripheral Vascular Reactivity and Serum BDNF Responses to Aerobic Training Are Impaired by the BDNF Val66Met Polymorphism. Physiological genomics2016, 48, 116-123. https://doi.org/10.1152/PHYSIOLGENOMICS.00086.2015.26603150

66. Asai, T.; Abe, D.; Doi, H.; Tanaka, C.; Ohishi, K.; Maeda, H.; Wada, T.; Takahashi, Y.; Nakahata, Y.; Shinohara, K. Characteristics of the BDNF Val66Met Polymorphism in Competitive Swimmers and Judo Athletes. Acta Medica Nagasakiensia2020, 64, 23-29. https://doi.org/10.11343/AMN.64.23.

67. Jacob, Y.; Chivers, P.; Anderton, R.S. Genetic Predictors of Match Performance in Sub-Elite Australian Football Players: A Pilot Study. Journal of Exercise Science & Fitness2019, 17, 41-46.

68. Mang, C.S.; McEwen, L.M.; MacIsaac, J.L.; Snow, N.J.; Campbell, K.L.; Kobor, M.S.; Ross, C.J.D.; Boyd, L.A. Exploring Genetic Influences Underlying Acute Aerobic Exercise Effects on Motor Learning. Scientific Reports 2017 7:12017, 7, 1-10. https://doi.org/10.1038/s41598-017-12422-3.560896728935933

69. Hashimoto, K. BDNF Variant Linked to Anxiety-Related Behaviors. BioEssays: news and reviews in molecular, cellular and developmental biology2007, 29, 116-119. https://doi.org/10.1002/BIES.20534.17226799

70. Fratelli, C.F.; Siqueira, J.W.; Gontijo, B.R.; Santos, M. de L.; Silva, C.M. de S.; Silva, I.C.R. da BDNF Genetic Variant and Its Genotypic Fluctuation in Major Depressive Disorder. Behavioural Neurology2021, 2021, 1-16. https://doi.org/10.1155/2021/7117613.857559834760029

71. Tajbakhsh, A.; Alimardani, M.; Asghari, M.; Abedini, S.; Saghafi Khadem, S.; Nesaei Bajestani, A.; Alipoor, F.; Alidoust, M.; Savardashtaki, A.; Hashemian, P.; et al. Association of PICK1 and BDNF Variations with Increased Risk of Methamphetamine Dependence among Iranian Population: A Case-Control Study. BMC medicalgenomics2021, 14. https://doi.org/10.1186/S12920-021-00873-7.

Opublikowane

2022-06-23